97 related articles for article (PubMed ID: 22908096)
21. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
22. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
24. Identification of expressed genes characterizing long-term survival in malignant glioma patients.
Yamanaka R; Arao T; Yajima N; Tsuchiya N; Homma J; Tanaka R; Sano M; Oide A; Sekijima M; Nishio K
Oncogene; 2006 Sep; 25(44):5994-6002. PubMed ID: 16652150
[TBL] [Abstract][Full Text] [Related]
25. Primary central nervous system lymphoma: immunohistochemical profile and prognostic significance.
Raoux D; Duband S; Forest F; Trombert B; Chambonnière ML; Dumollard JM; Khaddage A; Gentil-Perret A; Péoc'h M
Neuropathology; 2010 Jun; 30(3):232-40. PubMed ID: 19925562
[TBL] [Abstract][Full Text] [Related]
26. High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
Yoshihara K; Tsunoda T; Shigemizu D; Fujiwara H; Hatae M; Fujiwara H; Masuzaki H; Katabuchi H; Kawakami Y; Okamoto A; Nogawa T; Matsumura N; Udagawa Y; Saito T; Itamochi H; Takano M; Miyagi E; Sudo T; Ushijima K; Iwase H; Seki H; Terao Y; Enomoto T; Mikami M; Akazawa K; Tsuda H; Moriya T; Tajima A; Inoue I; Tanaka K;
Clin Cancer Res; 2012 Mar; 18(5):1374-85. PubMed ID: 22241791
[TBL] [Abstract][Full Text] [Related]
27. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
[TBL] [Abstract][Full Text] [Related]
29. Defective expression of HRK is associated with promoter methylation in primary central nervous system lymphomas.
Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
Oncology; 2006; 70(3):212-21. PubMed ID: 16809940
[TBL] [Abstract][Full Text] [Related]
30. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
Yuan J; Gu K; He J; Sharma S
Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
[TBL] [Abstract][Full Text] [Related]
31. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
32. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.
Roth P; Martus P; Kiewe P; Möhle R; Klasen H; Rauch M; Röth A; Kaun S; Thiel E; Korfel A; Weller M
Neurology; 2012 Aug; 79(9):890-6. PubMed ID: 22895585
[TBL] [Abstract][Full Text] [Related]
33. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiles of central nervous system lymphoma predict poor survival in patients with diffuse large B-cell lymphoma.
Kagoya Y; Nannya Y; Nakamura F; Kurokawa M
Br J Haematol; 2014 Sep; 166(5):794-7. PubMed ID: 24749697
[No Abstract] [Full Text] [Related]
35. Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.
Takashima Y; Hamano M; Yoshii K; Hayano A; Fukai J; Iwadate Y; Kajiwara K; Hondoh H; Yamanaka R
Int J Clin Oncol; 2023 Mar; 28(3):468-481. PubMed ID: 36607476
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.
Du KX; Shen HR; Pan BH; Luthuli S; Wang L; Liang JH; Li Y; Yin H; Li JY; Wu JZ; Xu W
Clin Transl Oncol; 2024 Mar; 26(3):720-731. PubMed ID: 37558851
[TBL] [Abstract][Full Text] [Related]
37. Proteomic characterization of primary diffuse large B-cell lymphomas in the central nervous system.
Li J; Okamoto H; Yin C; Jagannathan J; Takizawa J; Aoki S; Gläsker S; Rushing EJ; Vortmeyer AO; Oldfield EH; Yamanaka R; Zhuang Z
J Neurosurg; 2008 Sep; 109(3):536-46. PubMed ID: 18759588
[TBL] [Abstract][Full Text] [Related]
38. Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL).
Sasayama T; Tanaka K; Mizowaki T; Nagashima H; Nakamizo S; Tanaka H; Nishihara M; Mizukawa K; Hirose T; Itoh T; Kohmura E
Brain Pathol; 2016 Jul; 26(4):479-87. PubMed ID: 26314692
[TBL] [Abstract][Full Text] [Related]
39. Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma.
Sung CO; Kim SC; Karnan S; Karube K; Shin HJ; Nam DH; Suh YL; Kim SH; Kim JY; Kim SJ; Kim WS; Seto M; Ko YH
Blood; 2011 Jan; 117(4):1291-300. PubMed ID: 21088137
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors.
Korkola JE; Houldsworth J; Feldman DR; Olshen AB; Qin LX; Patil S; Reuter VE; Bosl GJ; Chaganti RS
J Clin Oncol; 2009 Nov; 27(31):5240-7. PubMed ID: 19770384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
